Millendo Therapeutics, Inc. Uncategorized Contracts & Agreements

32 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered Under Section 12 of the Exchange Act – Tempest Therapeutics, Inc.
Equity Distribution Agreements
Millendo Therapeutics, Inc.
Biotechnology
2025
Open Market Sale Agreement between Tempest Therapeutics, Inc. and Jefferies LLC (June 20, 2024)
Equity Distribution Agreements
Millendo Therapeutics, Inc.
Biotechnology
NY
2024
Description of Tempest Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Millendo Therapeutics, Inc.
Biotechnology
2024
Tempest Therapeutics, Inc. Inducement Stock Option Grant and Agreement (Nonstatutory)
Equity Distribution Agreements
Millendo Therapeutics, Inc.
Biotechnology
2023
Tempest Therapeutics, Inc. 2023 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Millendo Therapeutics, Inc.
Biotechnology
DE
2023
Public Company Support Agreement among Tempest Therapeutics, Millendo Therapeutics, and Stockholder
Voting Agreements
Millendo Therapeutics, Inc.
Biotechnology
DE
2021
Support Agreement among Tempest Therapeutics, Millendo Therapeutics, and Stockholder Regarding Merger
Voting Agreements
Millendo Therapeutics, Inc.
Biotechnology
DE
2021
Millendo Therapeutics Executive Chair Offer Letter to Julia C. Owens (January 2021)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2021
Description of Millendo Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Millendo Therapeutics, Inc.
Biotechnology
2020
Indemnification Agreement between Millendo Therapeutics, Inc. and Director or Officer
Indemnification Agreements
Millendo Therapeutics, Inc.
Biotechnology
DE
2018
OvaScience, Inc. Employment Offer Letter Agreement with Jonathan Gillis (June 14, 2017)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2017
Separation Agreement between OvaScience, Inc. and Paul Chapman dated December 21, 2016
Separation Agreements
Millendo Therapeutics, Inc.
Biotechnology
MA
2017
Separation Agreement between OvaScience, Inc. and Harald Stock dated December 21, 2016
Separation Agreements
Millendo Therapeutics, Inc.
Biotechnology
MA
2017
Binding Term Sheet to Amend Exclusive License Agreement between OvaScience, Inc. and Massachusetts General Hospital
Modification Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
OvaScience, Inc. Employment Agreement with Christophe Couturier (Chief Financial Officer)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
MA
2016
OvaScience, Inc. Employment Offer Letter to Paul Chapman (Chief Operating Officer)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
UK Assignment Letter Agreement between OvaScience Limited and Harald Stock (January 5, 2016)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
OvaScience, Inc. Employment Agreement with Harald Stock (CEO) dated January 5, 2016
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
OvaScience, Inc. Employment Agreement with Michelle Dipp, M.D. (Executive Chair)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
UK Assignment Letter Agreement between OvaScience Limited and Harald Stock (January 5, 2016)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
OvaScience, Inc. Employment Agreement with Harald Stock (CEO) Dated January 5, 2016
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
OvaScience, Inc. Executive Chair Employment Agreement with Michelle Dipp, M.D. (2016)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2016
OvaScience, Inc. Employment Offer Letter to David P. Harding as Chief Commercial Officer
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2015
OvaScience, Inc. Employment Offer Letter to Jeffrey E. Young as Chief Financial Officer
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2014
Exclusive Channel Collaboration Agreement between Intrexon Corporation and OvaXon, LLC (December 18, 2013)
Collaboration Agreements
Millendo Therapeutics, Inc.
Biotechnology
NY
2014
Exclusive Channel Collaboration Agreement between Intrexon Corporation and OvaScience, Inc.
Collaboration Agreements
Millendo Therapeutics, Inc.
Biotechnology
NY
2014
OvaScience, Inc. Employment Agreement with Arthur O. Tzianabos, Ph.D. (Chief Scientific Officer)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2013
OvaScience, Inc. Employment Offer Letter to Alison Lawton (Chief Operating Officer)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2013
OvaScience, Inc. Employment Agreement with Michelle Dipp, M.D. (President and CEO)
Employment Agreements
Millendo Therapeutics, Inc.
Biotechnology
2013
Lock-Up Agreement between Millendo Therapeutics, Inc. and Shareholder Regarding Merger with Tempest Therapeutics, Inc.
Millendo Therapeutics, Inc.
Biotechnology
2021
Intellectual Property License Agreement between OvaXon, LLC and OvaScience, Inc.
License Agreements
Millendo Therapeutics, Inc.
Biotechnology
NY
2014
OvaScience, Inc. and Scott Chappel Separation Agreement (July 2, 2013)
Separation Agreements
Millendo Therapeutics, Inc.
Biotechnology
MA
2013